Salinity is among the major global burdens limiting food production, natural or human induced, ~20% of the global irrigated
soils are already affected by salinity. Seed producers, aware of the billion-dollar business opportunity,...
see more
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Project Information SALICROP
Project duration: 5 months
Date Start: 2019-11-22
End date: 2020-04-30
Project leader
SALICROP LTD
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Project Budget
71K€
participation deadline
Sin fecha límite de participación.
Project description
Salinity is among the major global burdens limiting food production, natural or human induced, ~20% of the global irrigated
soils are already affected by salinity. Seed producers, aware of the billion-dollar business opportunity, have tried to
overcome the salinity barrier without success.
Salicrop Ltd, a Israeli Agtech startup, develops seed treatments for saline soil and water, which enables growing crops on
marginal land and/or irrigation with brackish water. Salicrop finalized its Proof of Concept (POC) with numerous successful
trials of tomatoes, peppers, spinach, rice, wheat and corn with average of 30% increase in crop yield under salinity
conditions. After successfully piloting the prototype version of seeds treatment bio-technology, the team can confirm the
capability of its breakthrough product to open new markets starting in Europe with the potential for rapid growth, licensing
our technology to key seed players to obtain a salt-tolerant version of their own commercial seed-varieties.
By pursuing the present feasibility study, Salicrop’s management team aims to improve its understanding of international
market conditions and the associated risks as the company develops a deeper business plan for rolling out and scaling up
seed treatments licensing as a marketable innovative solution. SME Instrument Phase-1 and Phase-2 will be extremely
beneficial in helping the company to accelerate development and market penetration of the developed solution in target
segments, boosting the company’s growth to 28 employees and $53,500,000 revenues by 2025.